Markus Goebel - Crunchbase Person Profile

Start Free Trial

Overview

CB Rank (Investor)

Location Basel, Basel-Stadt, Switzerland
Regions Europe, Middle East, and Africa (EMEA)
Gender Male

Investor Type
obfuscated
obfuscation

LinkedIn View on LinkedIn

Partner Investments

Number of Partner Investments

Announced Date	Organization Name	Investor Name	Lead Investor	Funding Round	Money Raised
obfuscated obfuscation	Merganser Biotech	Novartis Venture Fund	Yes	Series A - Merganser Biotech	obfuscated obfuscation
obfuscated obfuscation	Sorbent Therapeutics	Novartis Venture Fund	—	Series D - Sorbent Therapeutics	obfuscated obfuscation
obfuscated obfuscation	Sorbent Therapeutics	Novartis Venture Fund	—	Series C - Sorbent Therapeutics	obfuscated obfuscation
obfuscated obfuscation	Sorbent Therapeutics	Novartis Venture Fund	Yes	Series B - Sorbent Therapeutics	obfuscated obfuscation
obfuscated obfuscation	Trellis Bioscience	Novartis Venture Fund	Yes	Series B - Trellis Bioscience	obfuscated obfuscation

Jobs

Number of Past Jobs

has had

past jobs including

Head Pharma Corporate M&A

at

.

Organization Name	Title At Company	Start Date	End Date
Novartis	Head Pharma Corporate M&A	2002	2004
Novartis Venture Fund	Managing Director & Head Pharma Corporate M&A	2002	2004

Education

studied at

Ludwig Maximilian University of Munich

and

University of Hamburg

.

Ludwig Maximilian University of Munich MDunknown1979
University of Hamburg Ph.Dunknown

Events

Number of Events

has participated in

event,

Redefining Early Stage Investments (RESI) Conference @ Boston

on

Sep 6, 2018

.

Redefining Early Stage Investments (RESI) Conference @ Boston Speaker Boston, Massachusetts, United States, North AmericaSep 6, 2018

Recent News and Activity

Number of News Articles

News•

Feb 19, 2015

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated